Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Revenue: 2012-2025

Historic Revenue for Agios Pharmaceuticals (AGIO) over the last 13 years, with Sep 2025 value amounting to $12.9 million.

  • Agios Pharmaceuticals' Revenue rose 43.69% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.8 million, marking a year-over-year increase of 36.26%. This contributed to the annual value of $36.5 million for FY2024, which is 36.07% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Revenue of $12.9 million as of Q3 2025, which was up 3.41% from $12.5 million recorded in Q2 2025.
  • Agios Pharmaceuticals' 5-year Revenue high stood at $12.9 million for Q3 2025, and its period low was $832,000 during Q1 2022.
  • Over the past 3 years, Agios Pharmaceuticals' median Revenue value was $8.6 million (recorded in 2024), while the average stood at $8.9 million.
  • Data for Agios Pharmaceuticals' Revenue shows a peak YoY skyrocketed of 574.16% (in 2023) over the last 5 years.
  • Over the past 4 years, Agios Pharmaceuticals' Revenue (Quarterly) stood at $4.3 million in 2022, then surged by 64.80% to $7.1 million in 2023, then skyrocketed by 51.06% to $10.7 million in 2024, then surged by 43.69% to $12.9 million in 2025.
  • Its Revenue was $12.9 million in Q3 2025, compared to $12.5 million in Q2 2025 and $8.7 million in Q1 2025.